Articles tagged with Cannabis
A survey of Seattle area college students reveals that four-year college students drink nearly twice as much alcohol as their community college peers, while using marijuana nearly twice as often. The study suggests that perceptions of peer use may play a role in these differences.
A new case report highlights the risks of herbal supplements containing CBD and berberine, which can cause cardiac arrhythmias. The study involves a patient who experienced dizziness and fainting after taking high doses of hemp oil and berberine supplements, leading to a life-threatening condition.
The May issues of American Psychiatric Association journals explore the cognitive impacts of long-term cannabis use, the intersection of climate change and mental health, and tools to address children's mental health. The American Journal of Psychiatry and Psychiatric Services feature research reports on these topics.
A survey of veterinarians in the US and Canada reveals a significant increase in cannabis poisoning cases among pets since Canada's 2018 legalization, with most cases treated successfully. The study highlights the importance of understanding the effects of cannabis on pets to inform veterinary efforts and policies.
A new study led by NYU researchers found that cannabis edibles mimicking popular snack foods have high THC content and may be easily confused for them, increasing the risk of accidental ingestion by children. The products often exceeded maximum limits set by state regulations, raising concerns about public health.
A study by Cornell researchers found that recreational marijuana access significantly decreases prescriptions for pain, depression, anxiety, sleep, psychosis, and seizures in state Medicaid programs. This reduction could lead to significant cost savings for state Medicaid programs.
A new study by NIH-funded researchers shows that adolescents with severe substance use disorder symptoms are more likely to develop prescription drug misuse and overdose risks in adulthood. Screening for substance use disorder in teens may help predict adult problems and prevent overdoses.
Researchers found that social cannabis bong smoking in the home generates unsafe levels of measurable fine particulate matter, posing potential health risks. The study suggests that secondhand exposure can be hazardous and warrants further attention.
The rate of older adults treated for substance abuse increased sharply from 2000 to 2017, with a notable rise in cannabis and cocaine use. This trend is attributed to decreasing stigma around substance abuse, allowing more older adults to seek help through self-referrals.
Researchers at Massachusetts General Hospital found that medical marijuana users were more likely to develop cannabis use disorder (CUD) than expected, particularly those seeking relief from anxiety and depression. The study suggests that the current system of dispensing and using medical marijuana may be contributing to this issue.
A randomized clinical trial found that acquiring a medical marijuana card led to a higher incidence of cannabis use disorder but no significant improvement in symptoms of pain, anxiety, or depression. Immediate access to medical marijuana resulted in improved sleep.
A new study found that e-cigarette use significantly increases adolescents' risk of cannabis use, especially among those with externalizing mental health problems. However, for those with internalizing mental health issues, the relationship is reversed, and they are less likely to begin using cannabis.
A consensus advice document provides an overview of available cannabis medicines for treating epilepsy in children and adults, including dosing, interactions, and symptom relief. The guidance will be updated as new evidence emerges, providing structure for a future definitive guideline.
A research team at Leibniz-HKI has developed a new method to produce complex natural products, including the precursor to THC, in amoebae. By leveraging the natural properties of the amoeba, they were able to produce a functional inter-kingdom hybrid enzyme that produces olivetolic acid without additives.
A CAMH-led study found that repetitive transcranial magnetic stimulation (rTMS) reduced self-reported cannabis use by up to 60% among people with schizophrenia and CUD. The treatment was associated with reduced cravings and improved quality of life.
A 16-year study of over 2,000 Australian children shows that young people who use drugs but quit before adulthood have similar life success as those who never used drugs. The study highlights the importance of stopping drug use in early adulthood to prevent adult health and wellbeing issues.
A new synthetic substance, PECS-101, has been shown to prevent neuropathic pain caused by chemotherapy while improving cancer treatment outcomes. The study, conducted in mice, found that PECS-101 had no adverse effects and did not cause dependence.
LaTrice Montgomery, a University of Cincinnati researcher, emphasizes the need for more specific data on cannabis use among different racial and ethnic groups. Her research focuses on cannabis addiction, also known as cannabis use disorder (CUD), which is listed in industry standard handbooks alongside other stimulants.
Ontario residents aged 15 and older experienced a 190% increase in ED visits due to cannabis from January 2016 to May 2021. The rapid expansion of the legal market, combined with the COVID-19 pandemic, contributed to this surge.
A new study examines the 'skunk' smell and other emissions from cannabis production, finding they can be equivalent to livestock operations. The review highlights gaps in knowledge about cannabis emissions and their impact on air quality.
A new American Heart Association scientific statement highlights the need for caution when using marijuana due to its impact on brain health. Previous animal studies suggest that THC can disrupt memory, learning, and brain development, particularly in adolescence. The statement also raises concerns about the risks of cannabis use durin...
A study of drivers with past-year alcohol and cannabis use found that two in five reported driving under the influence of alcohol, cannabis, or both. Simultaneous use was associated with a higher risk of DUI, particularly among young adolescents.
A recent study found that cannabis-related emergency department visits among adolescents and young adults in Ontario rose nearly five-fold between 2003 and 2017. The study highlights an emerging public health problem and emphasizes the need for further research into the causes of this trend.
A recent study published in JAMA Pediatrics has estimated that a significant proportion of e-cigarette users among youth ages 12 to 24 are also vaping cannabis. The study found an association between cannabis vaping and increased risk of mental health issues, highlighting the need for further research and prevention efforts.
Researchers found that young adults with cannabis use disorder are more likely to experience recurrent strokes compared to those without the condition. The study suggests that chronic marijuana use may impair blood vessel function and increase the risk of future strokes.
A new study found that female adults who heavily used cannabis had a lower incidence of diabetes compared to those who did not use cannabis. In contrast, light cannabis use among females and male adults with any level or no cannabis use showed no association with diabetes diagnosis.
Research from the Dunedin Multidisciplinary Health and Development Study finds that prolonged cannabis use leads to over-inflated lungs and increased airway resistance, impairing oxygen extraction. This effect is distinct from tobacco use and may reflect early signs of a severe form of emphysema.
A recent study found that combining cannabis and alcohol significantly worsens driving performance compared to using either substance alone. This is because the effects of cannabis on driving are additive to those of alcohol, leading to impaired lane control and increased crash risks.
A two-year randomized trial found that cannabis use significantly impaired driving ability, particularly in the first few hours after smoking. Despite varying levels of THC content and user history, participants displayed diminished skills on simulated driving tests.
A study found that 31.4% of trauma patients at Hospital das Clínicas in São Paulo, Brazil, tested positive for psychoactive substance use, including alcohol (23%), cocaine (12%), and marijuana (5%). The study contributes to the development of public policies to prevent accidents.
A new study published in Fertility & Sterility found that chronic marijuana use negatively impacts male reproductive health, leading to decreased testicular size and lowered testosterone levels. The Oregon Health & Science University study used nonhuman primates to assess the effects of daily THC consumption on reproductive function.
A recent survey by Johns Hopkins Medicine researchers found that about 22% of young sexual minority males and transgender females engage in transactional sex. The practice is associated with HIV exposure, substance use disorder, and unstable housing. Researchers plan to develop interventions to address economic and social vulnerabilities.
Researchers found that CBN preserves mitochondrial function and prevents oxidative damage to nerve cells, suggesting potential for treating age-related neurodegenerative diseases like Alzheimer's. The compound works independently of cannabinoid receptors, making it a promising therapeutic option.
A systematic review of 43,000 participants found cannabis use leads to acute cognitive impairments that persist beyond intoxication. Cannabis intoxication impairs areas including concentration and memory, with potential consequences for daily life, education, and work performance.
A study published in Science Advances found that cannabidiol (CBD) inhibited SARS-CoV-2 infection in human cells and mice, suggesting its potential as a preventative or early treatment for COVID-19. CBD's effects were confined to high purity doses and specific situations.
A study found that recreational cannabis companies market their products in a way that appeals to children and teens, despite state-based regulations prohibiting it. The marketing is easily viewed by people of all ages on social media platforms.
A Montreal-based study found that alcohol, cannabis, and nicotine use remained stable among 24- to 33-year-olds from before the pandemic to now. However, people with lower education levels and those living alone were more likely to start or increase substance use during COVID-19.
A new study shows that California's legalized marijuana industry has boosted financial institutions' assets and loan activity, but restricted access to banking perpetuates inequities for licensed growers. The research highlights the need for regulatory changes to create new opportunities for both industries.
A large-scale survey of over 500 delta-8-THC users found they experience fewer negative side effects and use it in safer modalities compared to delta-9. The study's findings have significant implications for lawmakers, public health officials, and consumers as more states legalize cannabis while prohibiting delta-8.
Researchers at Massachusetts General Hospital have developed a portable brain imaging procedure using functional near-infrared spectroscopy (fNIRS) to detect acute impairment from THC intoxication. The technique shows promise in distinguishing between impairment and mild intoxication, with accuracy confirmed by machine learning models.
Research finds a heightened risk of bronchitic symptoms and shortness of breath among young adults exposed to secondhand nicotine vapour from e-cigarettes. Exposure to ultrafine particles, volatile compounds, and metals can harm lung tissue.
A significant increase in emergency department visits due to cannabis exposures among children was found after Canada's recreational cannabis legalization. The study suggests that the introduction of legal edible cannabis products contributed to this trend.
Emergency department visits for cannabis poisonings in children under 10 increased ninefold after commercial cannabis edibles were legalized, with 39% requiring hospitalization. Researchers found that cannabis legalization overlapped with the COVID-19 pandemic, leading to a surge in cannabis poisoning cases.
The January issues of American Psychiatric Association journals feature new research on the factors underlying alcohol and cannabis use, as well as their interactions with other psychiatric illnesses. The journals also address disparities in coercive treatment for psychosis and provide insights into mental health services delivery.
Researchers found that CBD shrinks glioblastoma tumors by reducing inflammation and restoring immune balance. The compound also suppresses key proteins involved in tumor growth and spread, making it a potential novel adjunct therapy for glioblastoma patients.
A study published in CMAJ found that people using cannabis during pregnancy and lactation do so to manage symptoms such as nausea and mental health problems. The motivations for use change when they become pregnant, with some stopping due to fear or stigma, while others continue to use it for symptom management.
Researchers at Tel Aviv University successfully treated autism in animal models with medical cannabis oil, improving behavioral and biochemical parameters. The treatment showed significant improvement in compulsive and anxious behaviors, and a decrease in the concentration of the arousing neurotransmitter glutamate.
A new study reveals that cannabis plants can absorb heavy metals from the soil, making them potentially toxic for consumers. The research proposes strategies for growers to avoid heavy metal uptake in their crops, including choosing farmland with low heavy metal content and selecting varieties not bred for phytoremediation.
The Monitoring the Future survey found a significant decrease in illicit drug use among adolescents in 2021, with notable declines in alcohol, marijuana, and vaping use. The survey also reported moderate increases in mental health indicators, highlighting an unexpected consequence of the COVID-19 pandemic.
A case series of 10 children with severe epilepsy found that whole plant medicinal cannabis reduced monthly seizure frequency by an average of 86%. The study suggests that whole plant products may be more effective than CBD products in treating childhood-onset severe treatment-resistant epilepsy.
New research suggests that cannabis use can lead to harmful drug-drug interactions by interfering with two families of enzymes that metabolize a wide range of drugs. This could result in unintended side effects such as toxicity or accidental overdose, particularly for older individuals using medications.
A University of Otago study surveyed 529 students to investigate factors influencing the switch from illicit to lawful cannabis sources. The main facilitator identified was perceived safety, with 63% of respondents citing this as a primary reason for sourcing cannabis through legal channels.
New research from the Prevention Research Center found that youth exposed to tobacco marketing were more likely to use both tobacco and cannabis on the same day. The study used GPS data and surveys to track youth travel patterns and exposure to tobacco outlets.
A study found that long-term cannabis smokers have increased levels of Actinomyces meyeri in their saliva, which correlates with the length of cannabis use. This bacterium was shown to decrease activity and increase beta-amyloid production in mice, suggesting a link between oral microbiome disruption and brain health.
A study of US adults found a link between cannabis use and extremes of nightly sleep duration, with recent users more likely to report short or long sleep. Heavy users were 64% more likely to experience short sleep and 76% more likely to experience long sleep compared to non-users.
A Washington State University study found that cannabis vapor exposure lowered sperm counts and slowed movement in male mice and their sons. The study suggests that cannabis use may be detrimental to male reproductive function, contributing to declining human sperm counts.
Researchers discovered a new family of prenylated volatile sulfur compounds responsible for the characteristic skunky smell of cannabis. The findings suggest these compounds could have medicinal properties and are being investigated further.
A nationwide survey of 387,000 US adults found that high-frequency cannabis use was associated with characteristics such as younger age and lower educational attainment. The study suggests that sociodemographic factors may play a role in cannabis use patterns.
A study found that budtenders and healthcare providers are seeking more training on interacting with pregnant and breastfeeding women about their cannabis use. Healthcare providers have a negative opinion of the effects of cannabis use, while budtenders perceive marijuana as a safer alternative to perinatal alcohol or cigarette use.
Research found that cannabis exposure during pregnancy is associated with higher levels of stress hormone cortisol, anxiety, and hyperactivity in children. Maternal cannabis use also suppresses immune-activating genes, predicting higher anxiety in offspring.